- MOQ20 Piece(s)
- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All over the world
Dactinomycin or Actinomycin-D, is an intergral part of many chemotherapeutic protocols for Paediatric tumours. Its proven efficacy and good tolerability make it a trustworthy anti cancer drug for Paediatric Oncologists. Indications: As a part of a combination chemotherapy andor multi-modality treatment regimen, for the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer
View More Details